Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

PubWeight™: 6.29‹?› | Rank: Top 1%

🔗 View Article (PMID 4735411)

Published in J Pediatr on April 01, 1973

Authors

C J Baker, F F Barrett, R C Gordon, M D Yow

Articles citing this

Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23

Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev (1981) 7.86

Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01

Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev (1998) 5.36

Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42

Identification of group B streptococci by immunofluorescence staining. Appl Microbiol (1974) 3.51

Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material. J Clin Microbiol (1975) 3.38

Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest (1976) 3.04

Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55

The rapid recognition of Lancefield group B haemolytic streptococci. J Clin Pathol (1974) 2.48

Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol (1975) 2.45

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23

Group B streptococci in human disease. Bacteriol Rev (1976) 2.20

Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15

Group B streptococci in the female genital tract. Br Med J (1976) 2.04

Characterization and incidence of pigment production by human clinical group B streptococci. J Clin Microbiol (1978) 1.74

Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother (1976) 1.72

Analysis of group B streptococcal types associated with disease in human infants and adults. J Clin Microbiol (1978) 1.71

Role of antibody and complement in opsonization of group B streptococci. Infect Immun (1978) 1.57

Rapid isolation and identification of group B streptococci from selective broth medium by slide co-agglutination test. J Clin Microbiol (1978) 1.55

Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect Immun (1984) 1.54

Opsonin system of the group B streptococcus. Infect Immun (1974) 1.53

Extracellular neuraminidase production by group B streptococci. Infect Immun (1977) 1.53

Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun (1980) 1.52

Prospective surveillance of neonatal meningitis. Arch Dis Child (1993) 1.44

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun (1990) 1.43

Rapid slide coagglutination test for identifying and typing group B streptococci. J Clin Microbiol (1977) 1.42

Strain specificity of opsonins for group B streptococci types II and III. Infect Immun (1979) 1.33

Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci. Infect Immun (1985) 1.33

Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis (2007) 1.31

Evaluation of four methods for detection of group B streptococcal colonization. J Clin Microbiol (1976) 1.28

Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27

Radioimmunoassay for measuring antibodies specific for group B streptococcal types Ia, Ib, Ic, II, and III. J Clin Microbiol (1976) 1.25

pH-dependent penicillin tolerance of group B streptococci. Antimicrob Agents Chemother (1981) 1.23

Antibody to group B Streptococcus type III in human sera measured by a mouse protection test. Infect Immun (1981) 1.22

Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1981) 1.22

Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med (1987) 1.13

Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus. Infect Immun (1982) 1.12

Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect Immun (1979) 1.10

Factors influencing adherence of group B streptococci to human vaginal epithelial cells. Infect Immun (1979) 1.10

Characterization of neuraminidases produced by various serotypes of group B streptococci. Infect Immun (1987) 1.07

Evaluation of rapid methods of identifying group B streptococci. J Clin Pathol (1980) 1.06

Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother (2009) 1.04

Direct detection of group B streptococci from vaginal specimens compared with quantitative culture. J Clin Microbiol (1990) 1.02

Rapid method for identification of group B streptococci in neonatal blood cultures. J Clin Microbiol (1981) 1.01

Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin. J Clin Microbiol (1980) 0.94

Prognosis for survival in neonatal meningitis: clinical and pathologic review of 52 cases. Can Med Assoc J (1978) 0.93

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2013) 0.92

Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci (2010) 0.91

Group B streptococcal infection: a review and update. Br J Vener Dis (1979) 0.90

Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci. Antimicrob Agents Chemother (1981) 0.90

Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog (2011) 0.89

Capsular Typing Method for Streptococcus agalactiae Using Whole-Genome Sequence Data. J Clin Microbiol (2016) 0.88

Neonatal group B streptococcal meningitis. Arch Dis Child (1984) 0.86

Antimicrobial therapy of experimental group B streptococcal infection in mice. Antimicrob Agents Chemother (1977) 0.86

Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III. Infect Immun (1981) 0.84

Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection? Vaccine (2014) 0.83

Group B streptococci in pharyngeal aspirates at birth and the early detection of neonatal sepsis. Arch Dis Child (1978) 0.83

Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci. J Clin Microbiol (1982) 0.83

Immunochemical cross-reactions between type III group B Streptococcus and type 14 Streptococcus pneumoniae. Infect Immun (1979) 0.80

Toxicity of group B Streptococcus agalactiae in adult rats. Infect Immun (1985) 0.80

Screening of type Ia and Ib Streptococcus agalactiae strains with high sialic acid levels by determination of susceptibility to tetracyclines. J Clin Microbiol (1989) 0.78

Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol (2016) 0.77

[Group B-streptococci in the female genitals (author's transl)]. Arch Gynakol (1975) 0.75

Bacteriological findings after premature rupture of the membranes. Arch Gynecol Obstet (1989) 0.75

Group B beta-hemolytic streptococci analysis of 242 isolations. J Natl Med Assoc (1977) 0.75

Fatal neonatal meningitis due to group B streptococci. Postgrad Med J (1975) 0.75

Perinatal and neonatal infections. West J Med (1975) 0.75

Articles by these authors

Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22

Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78

Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46

Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42

Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38

Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J (1992) 3.84

Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82

Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71

Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol (1993) 3.52

The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48

Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23

Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23

Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis (1987) 3.09

Active oxygen in plant pathogenesis. Annu Rev Phytopathol (1995) 3.02

Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA (1979) 3.00

Molecular cloning of a Pseudomonas syringae pv. syringae gene cluster that enables Pseudomonas fluorescens to elicit the hypersensitive response in tobacco plants. J Bacteriol (1988) 2.84

Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83

Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother (1972) 2.79

Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55

A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr (1972) 2.48

Involvement of plasma membrane calcium influx in bacterial induction of the k/h and hypersensitive responses in tobacco. Plant Physiol (1990) 2.46

Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr (1993) 2.45

Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38

Comparative pharmacokinetics of tobramycin and gentamicin. Clin Pharmacol Ther (1973) 2.38

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23

Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics (1976) 2.22

Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children. Curr Ther Res Clin Exp (1971) 2.17

Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15

Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14

Infections and antibiotic use among patients at Boston City Hospital, February, 1967. N Engl J Med (1968) 2.12

Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09

Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05

The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00

Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00

Adherence of Haemophilus influenzae to buccal epithelial cells. Infect Immun (1982) 1.97

Bacteremia due to serratia marcescens. N Engl J Med (1968) 1.96

Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95

Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol (1989) 1.87

Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83

Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79

Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun (1970) 1.78

Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics (1989) 1.78

Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76

Group B streptococcal vaccines. Rev Infect Dis (1985) 1.74

Group B streptococcal infections. Adv Intern Med (1980) 1.72

Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother (1976) 1.72

Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71

Group B streptococcal cellulitis-adenitis in infants. Am J Dis Child (1982) 1.71

Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females. J Adolesc Health Care (1983) 1.70

Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis (1988) 1.66

Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64

Congenital ring constrictions and intrauterine amputations. Am J Dis Child (1971) 1.62

Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61

Fulminant neonatal sepsis and necrotizing enterocolitis associated with a "nonenteropathogenic" strain of Escherichia coli. J Pediatr (1976) 1.56

Fecal indicator bacteria persistence under natural conditions in an ice-covered river. Appl Environ Microbiol (1976) 1.56

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56

A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis (2000) 1.53

Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am (1988) 1.53

Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis (1987) 1.51

Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes. J Pediatr (1972) 1.50

Klebsiella-Enterobacter at Boston City Hospital, 1967. Arch Intern Med (1970) 1.50

Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr (1985) 1.49

Commercial latex agglutination for detection of group B streptococcal antigen in body fluids. J Pediatr (1983) 1.47

Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest (1982) 1.47

Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr (2001) 1.47

Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis (1994) 1.43

A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res (1987) 1.42

Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis (1996) 1.41

Immune response of infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis (1984) 1.41

Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture. J Infect Dis (1977) 1.39

Enteric virus isolation in different cell cultures. Bull World Health Organ (1965) 1.39

Identification of sialic acid in polysaccharide antigens in group B Streptococcus. Infect Immun (1976) 1.38

Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36

Variations in HIV risk behaviors of incarcerated juveniles during a four-year period: 1989-1992. J Adolesc Health (1998) 1.36

Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics (2000) 1.35

Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis (2001) 1.33

Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. Pediatr Infect Dis J (1997) 1.33

Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA (1984) 1.31

Evaluation of four methods for detection of group B streptococcal colonization. J Clin Microbiol (1976) 1.28

Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (Bethesda) (1968) 1.28

Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis (1980) 1.27

In vitro susceptibility of Haemophilus influenzae to eight antibiotics. Antimicrob Agents Chemother (1974) 1.27

The penetration of broad-spectrum antibiotics into the cerebrospinal fluid. Ann N Y Acad Sci (1967) 1.26

Interferon in congenital rubella: response to live attenuated measles vaccine. J Immunol (1967) 1.26

Transient Activation of Plasmalemma K Efflux and H Influx in Tobacco by a Pectate Lyase Isozyme from Erwinia chrysanthemi. Plant Physiol (1986) 1.26

Electron microscopic definition of surface antigens of group B Streptococcus. J Infect Dis (1979) 1.25

In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J (1987) 1.24

The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies. Am J Obstet Gynecol (1980) 1.24